Xian Ping Lu
Algemeen Directeur bij SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Vermogen: 67 M $ op 30-04-2024
Actieve functies van Xian Ping Lu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Algemeen Directeur | 24-03-2018 | - |
| Voorzitter | 24-03-2018 | - | |
| Oprichter | 21-03-2001 | - | |
| Directeur/Bestuurslid | 21-03-2001 | 24-03-2018 | |
| Hoofd Techniek/Wetenschap/O&O | 21-03-2001 | 01-01-2020 | |
| President | 21-03-2001 | 24-03-2018 |
Loopbaan van Xian Ping Lu
Eerdere bekende functies van Xian Ping Lu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Galderma Research & Development SNC
 Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Corporate Officer/Principal | - | - |
Maxia Pharmaceuticals, Inc.
 Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Oprichter | - | - |
Opleiding van Xian Ping Lu
| Sichuan University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Statistieken
Internationaal
| China | 4 |
| Verenigde Staten | 2 |
| Frankrijk | 2 |
Operationeel
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
Galderma Research & Development SNC
Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Health Technology |
- Beurs
- Insiders
- Xian Ping Lu
- Ervaring
